Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin vs placebo for reducing interleukin-6 levels in operated infants
IRCT20200109046061N2Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in post-operative inflammation comparing Melatonin with Placebo (2 arms). Primary endpoint: Change in interleukin-6 (IL-6) level. Started Aug 2023; status: completed.
02
Drugs
melatonin
03
Conditions
post-operative inflammation
Beyond the preview
Go deeper on IRCT20200109046061N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200109046061N2.